Rivastigmine augmentation in the management of chronic schizophrenia with comorbid dementia: an open-label study investigating effects on cognition, behaviour and activities of daily living. [electronic resource]
Producer: 20050215Description: 319-24 p. digitalISSN:- 0268-1315
- Activities of Daily Living
- Aged
- Behavior -- drug effects
- Cholinesterase Inhibitors -- therapeutic use
- Chronic Disease
- Cognition -- drug effects
- Dementia -- complications
- Female
- Humans
- Male
- Phenylcarbamates -- therapeutic use
- Psychiatric Status Rating Scales
- Rivastigmine
- Schizophrenia -- complications
- Schizophrenic Psychology
- Sex Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.